Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 61,740 | 42,838 | 35,200 | 30,577 | 14,459 |
| Gross Profit | 61,740 | 42,838 | 35,200 | 30,577 | 14,459 |
| Operating Expenses | 109,194 | 105,431 | 98,093 | 74,216 | 49,936 |
| Operating Income | -47,454 | -62,593 | -62,893 | -43,639 | -35,477 |
| Interest Expense | 2,660 | 325 | 7 | 314 | 422 |
| Other Income | 2,942 | 1,796 | 3,230 | 8,781 | 9,905 |
| Pre-tax Income | -47,172 | -61,122 | -59,670 | -35,172 | -25,994 |
| Net Income Continuous | -47,172 | -61,122 | -59,670 | -35,172 | -25,994 |
| Net Income | $-47,172 | $-64,198 | $-59,670 | $-35,172 | $-25,994 |
| EPS Basic Total Ops | -5.18 | -7.91 | -7.98 | -4.90 | -4.41 |
| EPS Basic Continuous Ops | -5.21 | -7.56 | -7.98 | -4.90 | -4.37 |
| EPS Diluted Total Ops | -5.18 | -7.91 | -7.98 | -4.90 | -4.41 |
| EPS Diluted Continuous Ops | -5.21 | -7.56 | -7.98 | -4.90 | -4.37 |
| EBITDA(a) | $-35,420 | $-51,178 | $-52,582 | $-37,859 | $-32,856 |